Atlas Trials

The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients

Clinical trial NCT04839237 · WITHDRAWN

Trial details

NCT number
NCT04839237
Sponsor
Xiangya Hospital of Central South University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2017-12-01
Primary completion
2020-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.